WallStreetZenWallStreetZen

NASDAQ: BCDA
Biocardia Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their BCDA stock forecasts and price targets.

Forecast return on equity

Is BCDA forecast to generate an efficient return?

Company
-486.27%
Industry
26.99%
Market
155.22%
BCDA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is BCDA forecast to generate an efficient return on assets?

Company
-127.51%
Industry
3.34%
BCDA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BCDA earnings per share forecast

What is BCDA's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.64
Avg 2 year Forecast
-$0.52
Avg 3 year Forecast
-$0.40

BCDA revenue forecast

What is BCDA's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$4.2M

BCDA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BCDA$1.14N/AN/A
BIVI$1.65N/AN/A
AKTX$5.40$33.50+520.37%Strong Buy
HOTH$0.75$5.00+570.24%Strong Buy
KAPA$0.57$9.00+1,492.92%Strong Buy
View Top Biotech Stocks

Biocardia Stock Forecast FAQ

What is BCDA's earnings growth forecast for 2026-2028?

(NASDAQ: BCDA) Biocardia's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.61%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 70.16%.

Biocardia's earnings in 2026 is -$8,228,000.On average, 4 Wall Street analysts forecast BCDA's earnings for 2026 to be -$7,030,283, with the lowest BCDA earnings forecast at -$7,612,311, and the highest BCDA earnings forecast at -$6,318,065. On average, 4 Wall Street analysts forecast BCDA's earnings for 2027 to be -$5,635,386, with the lowest BCDA earnings forecast at -$6,004,076, and the highest BCDA earnings forecast at -$5,169,326.

In 2028, BCDA is forecast to generate -$4,352,080 in earnings, with the lowest earnings forecast at -$4,288,626 and the highest earnings forecast at -$4,365,208.

If you're new to stock investing, here's how to buy Biocardia stock.

What is BCDA's revenue growth forecast for 2026-2028?

(NASDAQ: BCDA) Biocardia's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 50.86%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.32%.

Biocardia's revenue in 2026 is $0.On average, 4 Wall Street analysts forecast BCDA's revenue for 2026 to be $0, with the lowest BCDA revenue forecast at $0, and the highest BCDA revenue forecast at $0. On average, 4 Wall Street analysts forecast BCDA's revenue for 2027 to be $0, with the lowest BCDA revenue forecast at $0, and the highest BCDA revenue forecast at $0.

In 2028, BCDA is forecast to generate $46,310,595 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $95,345,342.

What is BCDA's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: BCDA) forecast ROA is -127.51%, which is lower than the forecast US Biotechnology industry average of 3.34%.

What is BCDA's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: BCDA) Biocardia's current Earnings Per Share (EPS) is -$1.23. On average, analysts forecast that BCDA's EPS will be -$0.64 for 2026, with the lowest EPS forecast at -$0.70, and the highest EPS forecast at -$0.58. On average, analysts forecast that BCDA's EPS will be -$0.52 for 2027, with the lowest EPS forecast at -$0.55, and the highest EPS forecast at -$0.47. In 2028, BCDA's EPS is forecast to hit -$0.40 (min: -$0.39, max: -$0.40).

What is BCDA's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: BCDA) forecast ROE is -486.27%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.